Table 2.
Study cohort | Diagnostic group | No. of subjects | Age (years) | Sex |
---|---|---|---|---|
LREN | 16p11.2 Del | 11 | 22.87, SD 13.64 | M: 7/F: 4 |
Healthy controls | 29 | 40.68, SD 11.85 | M: 16/F: 13 | |
UMon | 16p11.2 Del | 2 | 42.09, SD 19.06 | M: 2/F: 0 |
Healthy controls | 43 | 35.73, SD 15.07 | M: 19/F: 24 | |
CHUV | 16p11.2 Del | 12 | 6.17, SD 1.70 | M: 9/F: 3 |
Healthy controls | 33 | 6.23, SD 1.83 | M: 12/F: 21 | |
SVIP | 16p11.2 Del | 41 | 14.03, SD 10.03 | M: 25/F: 16 |
Healthy controls | 106 | 25.92, SD 14.76 | M: 58/F: 48 | |
UKBB | 16p11.2 Del | 4 | 65.65, SD 3.25 | M: 3/F: 1 |
Healthy controls | 767 | 62.76, SD 7.32 | M: 360/F: 407 | |
HCP | Healthy controls | 399 | 29.07, SD 3.77 | M: 182/F: 217 |
TOTAL | 16p11.2 Del | 70 | 17.82, SD 16.65 | M: 46/F: 24 |
Healthy controls | 1377 | 47.50, SD 19.25 | M: 647 /F: 730 |
LREN, UMon, CHUV, SVIP, UKBB and HCP are independent studies.